What is Veradermics Inc's EV/FCF?

Veradermics Inc (MANE) EV/FCF is -37.64x based on the latest available daily valuation data on Chartloom.

How to interpret EV/FCF for Veradermics Inc?

Interpreting EV/FCF for Veradermics Inc depends on industry, growth expectations, profitability, and peer multiples.

How do you interpret Enterprise Value to Free Cash Flow (EV/FCF)?

One of the most rigorous cash-based valuation multiples.

What should investors consider when analyzing Enterprise Value to Free Cash Flow (EV/FCF)?

FCF volatility from CapEx timing should be considered.

Veradermics Inc

$MANE

Health Care · Pharmaceuticals

Run Scenarios

$116.26

-5.02%

Veradermics Inc

$MANE

Health Care · Pharmaceuticals

Run Scenarios

$116.26

-5.02%

Overview AI Summary Charts Financials Valuation

Valuation Charts

Recent EV/FCF history

Daily readings for the most recent trading days on record.

Date	EV/FCF
Oct 13, 2026	-37.64x
Oct 12, 2026	-40.02x
Oct 9, 2026	-43.33x
Oct 8, 2026	-41.66x
Oct 7, 2026	-35.56x
Oct 6, 2026	-34.78x
Oct 5, 2026	-38.64x
Oct 2, 2026	-37.82x

How is EV/FCF calculated?

EV/FCF = Enterprise Value / Free Cash Flow (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).

How to interpret EV/FCF

EV/FCF is especially insightful for capital-intensive businesses.

One of the most rigorous cash-based valuation multiples.
FCF volatility from CapEx timing should be considered.

Frequently asked questions

P/S Ratio P/E Ratio Forward P/E Ratio P/FCF Ratio FCF Yield EV/Sales EV/EBITDA All Valuation Charts

Metric definition

Read the general EV/FCF definition, formula, and analyst usage guide.

EV/FCF guide

Informational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.

Overview AI Summary Charts Financials Valuation

Veradermics Inc (MANE) EV/FCF: -37.64x

Enterprise value divided by trailing twelve-month free cash flow. Values the entire business on cash available after reinvestment.

Latest EV/FCF

-37.64x

As of Oct 13, 2026

EV/FCF

All ChartsAll Valuation Charts

Explore Veradermics Inc's full valuation history

Beyond EV/FCF, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.

View All Valuation Charts